Bronchiolitis obliterans syndrome associated with an immune checkpoint inhibitor in a patient with non-small cell lung cancer

Bronchiolitis obliterans syndrome associated with an immune checkpoint inhibitor in a patient with non-small cell lung cancer

A 75-year-old woman was admitted to our hospital with progressive dyspnea 7 months after second-line treatment with pembrolizumab for advanced non-small cell lung cancer. Chest radiography revealed hyperinflation in both lung fields, and pulmonary function tests revealed severe obstructive dysfuncti...

Full description

Bibliographic Details
Main Authors: Kenichiro Takeda, Hideki Miwa, Masato Kono, Ryutaro Hirama, Yuiko Oshima, Yasutaka Mochizuka, Akari Tsutsumi, Yoshihiro Miki, Dai Hashimoto, Hidenori Nakamura
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:Respiratory Medicine Case Reports
Subjects:
Non-small cell lung cancer
Bronchiolitis obliterans syndrome
Immune checkpoint inhibitor
Pembrolizumab
Immune-related adverse events
Online Access:http://www.sciencedirect.com/science/article/pii/S2213007123000199

Internet

http://www.sciencedirect.com/science/article/pii/S2213007123000199

Similar Items